BPC-157 + TB-500

BPC-157 + TB-500: A two-component blend; the selected variant specifies each component amount.

What is it?

A two-component blend; the selected variant specifies each component amount.

How it is studied

Both components are associated with tissue-response research through different proposed mechanisms. Combining them creates a separate experimental material.

What the evidence says

Individual-compound publications do not demonstrate that the combination is additive, synergistic, or safer. Strong human evidence for this exact blend is lacking.

What remains uncertain

The 5 + 5 mg and 10 + 10 mg variants are distinct. TB-500 identity also requires confirmation. Stability, interactions, and safety cannot be inferred from the ingredients separately.

Sources & scope

Systematic review of musculoskeletal evidence (2025)

Thymosin beta-4 ophthalmic study

For in-vitro laboratory research only. Not for human or veterinary use.